» Articles » PMID: 29258998

Contractile Reserve As a Predictor of Prognosis in Patients with Non-ischaemic Systolic Heart Failure and Dilated Cardiomyopathy: a Systematic Review and Meta-analysis

Overview
Journal Echo Res Pract
Date 2017 Dec 21
PMID 29258998
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Patients with non-ischaemic systolic heart failure (HF) and idiopathic dilated cardiomyopathy (DCM) are a heterogenous group with varied morbidity and mortality. Prognostication in this group is challenging. We performed a systematic review and meta-analysis to examine the significance of the presence of contractile reserve as assessed via stress imaging on mortality and hospitalisation.

Methods: A search for studies that non-invasively assessed contractile reserve in patients with DCM or non-ischaemic HF with reduced ejection fraction, stress imaging with follow-up data comparing outcomes. A range of imaging modalities and stressors were included. We examined primary endpoints of mortality and secondary endpoints of combined cardiovascular events including HF progression or hospitalisation. Our analysis compared endpoints in patients with contractile reserve and those without it.

Results: Nine prospective cohort studies were identified describing a total of 787 patients. These studies are methodologically but not statistically heterogenous ( = 31%). Using a random effect model, the presence of contractile reserve was associated with a significantly lower risk of mortality and cardiovascular events odds ratios of 0.20 (CI 0.11, 0.39) ( < 0.00001) and 0.13 (CI 0.04, 0.40) ( = 0.0004), respectively.

Conclusion: Regardless of stressor and imaging modality and despite the significant methodological heterogeneity within the current data (imaging techniques and parameters), patients with non-ischaemic cardiomyopathy and reduced EF who demonstrate contractile reserve have a lower mortality, and lower events/hospitalisations. The presence of contractile reserve therefore offers a potential positive prognostic indicator when managing these patients.

Citing Articles

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations , , and .

Yang Z, Sheehan A, Messer A, Tsui S, Sparrow A, Redwood C Front Physiol. 2024; 15:1489439.

PMID: 39735723 PMC: 11672104. DOI: 10.3389/fphys.2024.1489439.


Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock.

Kanelidis A, Randazzo M, Kalantari S, Smith B, Nguyen A, Chung B Eur Heart J Open. 2024; 4(5):oeae072.

PMID: 39328214 PMC: 11425697. DOI: 10.1093/ehjopen/oeae072.


Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertension.

Brown J, Virsinskaite R, Kotecha T, Steeden J, Fontana M, Karia N Eur Heart J Cardiovasc Imaging. 2024; 25(12):1712-1720.

PMID: 39159164 PMC: 11601748. DOI: 10.1093/ehjci/jeae177.


The Utility of Low-Dose-Dobutamine Stress Echocardiography in Patients with Heart Failure with Reduced Ejection Fraction: An Update.

Tsigkriki L, Kleitsioti P, Dimitriadis F, Sidiropoulos G, Alkagiet S, Efstratiou D Diagnostics (Basel). 2023; 13(18).

PMID: 37761286 PMC: 10527914. DOI: 10.3390/diagnostics13182920.


Revascularisation for Ischaemic Cardiomyopathy.

Li Kam Wa M, Assar S, Kirtane A, Perera D Interv Cardiol. 2023; 18:e24.

PMID: 37655258 PMC: 10466461. DOI: 10.15420/icr.2023.06.


References
1.
Ramahi T, Longo M, Cadariu A, Rohlfs K, Slade M, Carolan S . Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Eur Heart J. 2001; 22(10):849-56. DOI: 10.1053/euhj.2001.2654. View

2.
Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E . The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2007; 99(8):1154-8. DOI: 10.1016/j.amjcard.2006.11.049. View

3.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special.... Eur J Heart Fail. 2016; 18(8):891-975. DOI: 10.1002/ejhf.592. View

4.
Matsumoto K, Tanaka H, Kaneko A, Ryo K, Fukuda Y, Tatsumi K . Contractile reserve assessed by three-dimensional global circumferential strain as a predictor of cardiovascular events in patients with idiopathic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012; 25(12):1299-308. DOI: 10.1016/j.echo.2012.09.018. View

5.
. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2011; 33(14):1750-7. DOI: 10.1093/eurheartj/ehr254. View